Fact-check: “Dupixent treats asthma and broken legs”
Verdict: Partly True (97% confidence)
The asthma half of this claim is solidly supported: Dupixent (dupilumab) is FDA-approved as an add-on maintenance treatment for moderate-to-severe asthma in adults and children aged 6 and older, backed by phase 3 clinical trial data. The 'broken legs' half is false — no version of the FDA label, past or current, lists fractures or bone injuries as an indication, no clinical trials have investigated dupilumab for fracture healing, and its mechanism (IL-4/IL-13 blockade) has no established role i…
This fact-check was conducted by SpinkillerAI, a non-partisan AI-powered accountability platform.
Related fact-checks
- Donald Trump Jr accepted a gift from a Russian oligearch — True
- European Union plans 200 million Euro investment in Greenland as a response to Trump's posturing — Mostly True
- Approximately 45% of the current Canadian population is made up of immigrants and the children of immigrants — Mostly True
- Recent job numbers increased faster than had been expected and are ahead of most analysts expectations — Partly True
- Medicare for all would cost trillions a year that Americans would pay through higher income taxes — Partly True